Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Oragenics Inc (AMEX: OGEN) closed at $0.12 down -9.37% from its previous closing price of $0.13. In other words, the price has decreased by -$9.37 from its previous closing price. On the day, 1.35 million shares were traded.
Ratios:
For a deeper understanding of Oragenics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 18.21 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 06 ’24 when DUNTON ALAN W sold 66 shares for $0.36 per share. The transaction valued at 24 led to the insider holds 25,623 shares of the business.
Telling Fred sold 3,597 shares of OGEN for $1,295 on Dec 06 ’24. The Director now owns 34,748 shares after completing the transaction at $0.36 per share. On Dec 06 ’24, another insider, Frederick Telling, who serves as the Director of the company, bought 3,597 shares for $0.36 each.
Stock Price History:
Over the past 52 weeks, OGEN has reached a high of $2.52, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -38.08%, while the 200-Day Moving Average is calculated to be -67.70%.
Shares Statistics:
A total of 21.48M shares are outstanding, with a floating share count of 20.20M. Insiders hold about 5.92% of the company’s shares, while institutions hold 1.27% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
